Fibromatosis-like metaplastic carcinoma: a case report and review of the literature.
Breast
Low-grade fibromatosis-like metaplastic carcinoma
Metaplastic breast carcinoma
Spindle cell lesion
Journal
Diagnostic pathology
ISSN: 1746-1596
Titre abrégé: Diagn Pathol
Pays: England
ID NLM: 101251558
Informations de publication
Date de publication:
03 Mar 2020
03 Mar 2020
Historique:
received:
04
12
2019
accepted:
26
02
2020
entrez:
5
3
2020
pubmed:
5
3
2020
medline:
26
11
2020
Statut:
epublish
Résumé
We report an unusual case of low-grade fibromatosis-like metaplastic carcinoma (LG-FLMC) of the breast. This exceedingly rare epithelial breast malignancy has been reported only 68 times in the past 20 years, and is classified as a subtype of metaplastic breast carcinoma (MBC). It is a locally aggressive tumor with a low potential for lymph node and distant metastases, but with a tendency to recur after excision. Here we describe a less common presentation of LG-FLMC, provide its molecular characterization, discuss the major differential diagnosis and bring a short review of the literature. A 65-year-old woman presented with a self-palpated breast lump that had discordant radio-pathological features. While imaging results were compatible with an infiltrative malignancy, on core needle biopsy (CNB) a sharply delineated lesion composed by a bland-looking population of spindle cells was observed; excision was recommended for final diagnosis. Histology of the resection specimen showed small areas of epithelial differentiation and foci of peripheral invasion. Immunohistochemical analysis revealed a co-immunoreactivity for epithelial and myoepithelial markers in the spindle cell component. Mutation analysis with a capture-based next generation sequencing method revealed pathogenic mutations in GNAS, TERT-promotor and PIK3R1 genes. A diagnosis of LG-FLMC was rendered. This case highlights the importance of a broad differential diagnosis, exhaustive sampling and the use of a broad immunohistochemical panel whenever dealing with a low-grade spindle cell lesion in the breast, and provides further insights into the molecular background of LG-FLMC.
Sections du résumé
BACKGROUND
BACKGROUND
We report an unusual case of low-grade fibromatosis-like metaplastic carcinoma (LG-FLMC) of the breast. This exceedingly rare epithelial breast malignancy has been reported only 68 times in the past 20 years, and is classified as a subtype of metaplastic breast carcinoma (MBC). It is a locally aggressive tumor with a low potential for lymph node and distant metastases, but with a tendency to recur after excision. Here we describe a less common presentation of LG-FLMC, provide its molecular characterization, discuss the major differential diagnosis and bring a short review of the literature.
CASE PRESENTATION
METHODS
A 65-year-old woman presented with a self-palpated breast lump that had discordant radio-pathological features. While imaging results were compatible with an infiltrative malignancy, on core needle biopsy (CNB) a sharply delineated lesion composed by a bland-looking population of spindle cells was observed; excision was recommended for final diagnosis. Histology of the resection specimen showed small areas of epithelial differentiation and foci of peripheral invasion. Immunohistochemical analysis revealed a co-immunoreactivity for epithelial and myoepithelial markers in the spindle cell component. Mutation analysis with a capture-based next generation sequencing method revealed pathogenic mutations in GNAS, TERT-promotor and PIK3R1 genes. A diagnosis of LG-FLMC was rendered.
CONCLUSION
CONCLUSIONS
This case highlights the importance of a broad differential diagnosis, exhaustive sampling and the use of a broad immunohistochemical panel whenever dealing with a low-grade spindle cell lesion in the breast, and provides further insights into the molecular background of LG-FLMC.
Identifiants
pubmed: 32127014
doi: 10.1186/s13000-020-00943-x
pii: 10.1186/s13000-020-00943-x
pmc: PMC7053053
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
20Références
Histopathology. 2016 Jan;68(1):33-44
pubmed: 26768028
Arch Pathol Lab Med. 2006 May;130(5):e81-3
pubmed: 16683904
World J Surg Oncol. 2007 Feb 27;5:24
pubmed: 17324295
Clin Breast Cancer. 2012 Apr;12(2):147-50
pubmed: 22444721
Int J Clin Exp Pathol. 2018 Jul 01;11(7):3691-3696
pubmed: 31949751
J Clin Pathol. 2015 May;68(5):362-7
pubmed: 25713418
Mod Pathol. 2018 Nov;31(11):1661-1674
pubmed: 29946183
Cancer. 1999 May 15;85(10):2170-82
pubmed: 10326695
Tumori. 2009 Mar-Apr;95(2):264-7
pubmed: 19579879
Histopathology. 2018 Aug;73(2):273-283
pubmed: 29537649
Cesk Patol. 2002 Oct;38(4):164-8
pubmed: 12629863
Nat Commun. 2018 May 8;9(1):1816
pubmed: 29739933
Am J Pathol. 2017 Oct;187(10):2139-2151
pubmed: 28736315
Mod Pathol. 2010 Nov;23(11):1438-48
pubmed: 20693983
Nat Med. 2017 Jun;23(6):703-713
pubmed: 28481359
Clin Cancer Res. 2017 Jul 15;23(14):3859-3870
pubmed: 28153863
J Pathol. 2018 Jul;245(3):373-383
pubmed: 29708279
Am J Surg Pathol. 2001 Aug;25(8):1009-16
pubmed: 11474284
Arch Pathol Lab Med. 2015 Apr;139(4):552-7
pubmed: 25822766
Appl Immunohistochem Mol Morphol. 2018 Oct;26(9):648-653
pubmed: 28027119
Semin Diagn Pathol. 2017 Sep;34(5):400-409
pubmed: 28629810
Mod Pathol. 2019 Mar;32(Suppl 2):1-178
pubmed: 30886301